Overview
KPV is classified as a healing peptide in Milligram's compound library. Tripeptide (Lys-Pro-Val) derived from the C-terminal fragment of alpha-melanocyte-stimulating hormone.
With a half-life of ~2 hours, KPV requires daily administration in most observed protocols. Administered via SubQ and oral injection, it has a bioavailability of approximately 95% via its primary route.
Half-life approximately 2 hours. Supports both subcutaneous and oral administration routes. One-compartment model.
Mechanism of Action
KPV's pharmacological activity involves the following key pathways:
Tissue Repair Signaling
KPV interacts with cellular repair pathways. Its mechanism involves modulation of growth factors and signaling cascades relevant to tissue recovery.
Systemic Distribution
After subcutaneous administration, KPV enters systemic circulation and distributes to target tissues where it exerts its pharmacological effects.
Dosing Protocols
The following protocols represent commonly observed dosing patterns. These are observational summaries, not recommendations.
Dose
200 mcg/day
Route
Subcutaneous
Frequency
2-3 times daily
Duration
4-12 weeks
Dose
500 mcg/day
Route
Subcutaneous
Frequency
2-3 times daily
Duration
4-12 weeks
Reconstitution Steps
KPV is supplied as a lyophilized (freeze-dried) powder and requires reconstitution before use. Common vial sizes: 5 mg, 10 mg.
-
1
Gather Supplies
Collect the KPV lyophilized vial, bacteriostatic water, alcohol swabs, a mixing syringe, and insulin syringes for dosing.
-
2
Swab Vial Tops
Clean the rubber stoppers on both the KPV vial and bacteriostatic water vial with alcohol swabs. Allow to air dry for 10 seconds.
-
3
Add Bacteriostatic Water
For a 5 mg vial, slowly inject 2 mL of bacteriostatic water along the inner wall of the vial. This yields a concentration of 2,500 mcg/mL. For a 10 mg vial with 2 mL, the concentration is 5,000 mcg/mL.
-
4
Gently Mix
Swirl the vial gently in a circular motion until the powder is fully dissolved. Do not shake vigorously as this can degrade the peptide.
-
5
Withdraw Your Dose
Using a 100-unit insulin syringe, draw the appropriate volume for your dose. For a 5 mg vial reconstituted with 2 mL, 250 mcg equals 10 units and 500 mcg equals 20 units.
-
6
Store Properly
Refrigerate the reconstituted vial at 2–8°C immediately after use. Keep away from light. Use within 4 weeks of reconstitution.
Quick Reconstitution Math
5 mg vial + 2 mL bac water = 2,500 mcg/mL. For a 250 mcg dose, draw 10 units on a 100-unit insulin syringe. For 500 mcg, draw 20 units. Use the Milligram reconstitution calculator for custom vial sizes.
Stable for up to 4 weeks refrigerated at 2–8°C when reconstituted with bacteriostatic water. Lyophilized powder is stable for 12+ months refrigerated. Do not freeze reconstituted solution.
Frequently Asked Questions
What is KPV and how does it work?
KPV is a tripeptide (Lysine-Proline-Valine) derived from the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). It inhibits nuclear factor kappa B (NF-κB), a master regulator of inflammatory gene expression, thereby reducing production of pro-inflammatory cytokines including TNF-alpha, IL-6, and IL-1β. Notably, its anti-inflammatory activity is not mediated through melanocortin receptors but through the PepT1 di/tripeptide transporter, which is upregulated in inflamed intestinal tissue.
What is the half-life of KPV?
KPV has an estimated half-life of approximately 30 minutes due to its small tripeptide structure and rapid systemic clearance. This short half-life means plasma levels reach steady state within hours of consistent daily dosing. Despite the brief circulating half-life, KPV's intracellular anti-inflammatory effects – mediated through NF-κB inhibition – persist beyond the plasma clearance window.
Can KPV be taken orally instead of injected?
KPV is one of the few peptides that retains bioavailability when administered orally, a rare property among therapeutic peptides that typically require injection to avoid gastrointestinal degradation. Oral KPV is transported across the intestinal epithelium via the PepT1 transporter, which has a high affinity for this tripeptide. Oral administration is particularly well-suited for targeting gut inflammation directly, as KPV is absorbed by the inflamed colonic cells where PepT1 expression is upregulated.
How long does KPV take to show effects?
For gut-related applications, reduced bloating and improved digestive comfort are commonly reported within 1–2 weeks of consistent use. Broader systemic anti-inflammatory effects are typically observed over 2–4 weeks. Full mucosal healing and sustained improvements generally require 6–8 weeks or longer of consistent administration.
Does KPV have antimicrobial properties?
In addition to its anti-inflammatory activity, KPV has demonstrated direct antimicrobial effects against Staphylococcus aureus and Candida albicans at picomolar concentrations in research settings. This dual anti-inflammatory and antimicrobial profile distinguishes it from single-mechanism compounds. The antimicrobial activity is attributed to the same α-MSH-derived signaling pathway that modulates immune responses.
What are the common side effects of KPV?
Preclinical studies suggest KPV is generally well tolerated with a favorable safety profile compared to conventional anti-inflammatory agents. Transient mild gastrointestinal discomfort and injection site irritation are the most commonly reported effects. Because KPV does not activate melanocortin receptors at typical doses, skin pigmentation changes – which are observed with full-length α-MSH – are not a reported concern.